BlackRock’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190K | Sell |
480,933
-112,964
| -19% | -$44.7K | ﹤0.01% | 4609 |
|
|
2025
Q1 | $206K | Sell |
593,897
-44,509
| -7% | -$15.4K | ﹤0.01% | 4549 |
|
|
2024
Q4 | $377K | Buy |
638,406
+43,139
| +7% | +$25.5K | ﹤0.01% | 4438 |
|
|
2024
Q3 | $1.05M | Sell |
595,267
-196,293
| -25% | -$345K | ﹤0.01% | 4113 |
|
|
2024
Q2 | $1.08M | Sell |
791,560
-1,988,141
| -72% | -$2.72M | ﹤0.01% | 4105 |
|
|
2024
Q1 | $9.56M | Sell |
2,779,701
-104,313
| -4% | -$359K | ﹤0.01% | 3318 |
|
|
2023
Q4 | $7.09M | Sell |
2,884,014
-229,366
| -7% | -$564K | ﹤0.01% | 3479 |
|
|
2023
Q3 | $5.29M | Sell |
3,113,380
-85,402
| -3% | -$145K | ﹤0.01% | 3581 |
|
|
2023
Q2 | $9.6M | Buy |
3,198,782
+2,215,270
| +225% | +$6.65M | ﹤0.01% | 3365 |
|
|
2023
Q1 | $2.64M | Sell |
983,512
-31,691
| -3% | -$84.9K | ﹤0.01% | 3844 |
|
|
2022
Q4 | $8.38M | Buy |
1,015,203
+213,556
| +27% | +$1.76M | ﹤0.01% | 3415 |
|
|
2022
Q3 | $6.17M | Buy |
801,647
+114,052
| +17% | +$878K | ﹤0.01% | 3591 |
|
|
2022
Q2 | $1.96M | Sell |
687,595
-906,643
| -57% | -$2.58M | ﹤0.01% | 4172 |
|
|
2022
Q1 | $7.97M | Buy |
1,594,238
+8,344
| +0.5% | +$41.7K | ﹤0.01% | 3629 |
|
|
2021
Q4 | $31.1M | Buy |
1,585,894
+315,203
| +25% | +$6.19M | ﹤0.01% | 2947 |
|
|
2021
Q3 | $37.4M | Buy |
1,270,691
+178,914
| +16% | +$5.27M | ﹤0.01% | 2820 |
|
|
2021
Q2 | $46.3M | Buy |
1,091,777
+124,406
| +13% | +$5.27M | ﹤0.01% | 2712 |
|
|
2021
Q1 | $49.2M | Buy |
967,371
+820,538
| +559% | +$41.7M | ﹤0.01% | 2582 |
|
|
2020
Q4 | $4.99M | Buy |
+146,833
| New | +$4.99M | ﹤0.01% | 3637 |
|